NCT01327846 Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) Status COMPLETED Phase PHASE3
NCT01327664 Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis Status WITHDRAWN Phase PHASE3
NCT01327053 A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01326845 Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study Status TERMINATED Phase PHASE4
NCT01324492 Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor Status COMPLETED Phase PHASE1
NCT01324479 Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01320358 Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients Status COMPLETED Phase PHASE2
NCT01318941 Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting Status COMPLETED Phase N/A
NCT01317615 RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation Status COMPLETED Phase PHASE4
NCT01317004 Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change Status COMPLETED Phase PHASE4
NCT01316601 A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease Status COMPLETED Phase PHASE2
NCT01316458 Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy Status COMPLETED Phase PHASE2
NCT01315275 A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema Status COMPLETED Phase PHASE4
NCT01315249 QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01313689 Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT01313559 Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer Status TERMINATED Phase PHASE2
NCT01310166 Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT01309698 Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01305941 A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2